Canada markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0300+0.0200 (+1.98%)
At close: 04:00PM EST
1.0500 +0.02 (+1.94%)
After hours: 07:57PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 63.10M
Enterprise Value 35.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)28.03
Price/Book (mrq)N/A
Enterprise Value/Revenue 16.00
Enterprise Value/EBITDA -1.26

Trading Information

Stock Price History

Beta (5Y Monthly) 2.18
52-Week Change 3-9.65%
S&P500 52-Week Change 314.90%
52 Week High 31.8500
52 Week Low 30.6500
50-Day Moving Average 30.8895
200-Day Moving Average 31.0455

Share Statistics

Avg Vol (3 month) 3116.8k
Avg Vol (10 day) 361.55k
Shares Outstanding 562.41M
Implied Shares Outstanding 663.58M
Float 853.95M
% Held by Insiders 17.20%
% Held by Institutions 127.28%
Shares Short (Nov 14, 2023) 4292.88k
Short Ratio (Nov 14, 2023) 41.54
Short % of Float (Nov 14, 2023) 40.50%
Short % of Shares Outstanding (Nov 14, 2023) 40.47%
Shares Short (prior month Oct 12, 2023) 4344.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sept 29, 2023


Profit Margin 0.00%
Operating Margin (ttm)-821.19%

Management Effectiveness

Return on Assets (ttm)-41.62%
Return on Equity (ttm)-1,310.02%

Income Statement

Revenue (ttm)2.21M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)222.90%
Gross Profit (ttm)1.12M
EBITDA -29.93M
Net Income Avi to Common (ttm)-37.32M
Diluted EPS (ttm)-0.6100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.8M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)1.09M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.28
Book Value Per Share (mrq)-0.21

Cash Flow Statement

Operating Cash Flow (ttm)-24.24M
Levered Free Cash Flow (ttm)-21.66M